Status:
COMPLETED
Bupropion and Restless Legs Syndrome
Lead Sponsor:
East Tennessee State University
Conditions:
Restless Legs Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine if bupropion will improve the symptoms of restless legs syndrome (RLS).
Detailed Description
Adult patients with moderate to severe RLS will be recruited for the study. Those on medications which treat RLS will be asked to discontinue the medications for two weeks prior to beginning the study...
Eligibility Criteria
Inclusion
- clinical diagnosis of Restless Legs Syndrome
- Severity Scale score 15 or higher
Exclusion
- History of seizures
- History of alcohol use greater than 2 drinks per day or occasional binges of 5 or more drinks per day
- Suicidal thoughts/ideations
- Inability to return for follow up appointments at 3 and 6 weeks
- Lack of access to telephone
- Eating disorder
- Age less than 18
- Pregnancy
- Unwillingness or inability to discontinue any RLS medications
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00621517
Start Date
February 1 2008
End Date
July 1 2009
Last Update
March 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
East Tennessee State University
Johnson City, Tennessee, United States, 37614